Healthcare & Life Sciences
CereGate
Germany
1
Investors
About
CereGate develops minimally invasive computer-brain interface technology aimed at treating neurological disorders and restoring sensory and motor functions; the technology has been clinically tested in over 85 patients addressing movement, balance, and sensory impairments.
Explore CereGate's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.